Raphe 5-HT(1A) autoreceptors, but not postsynaptic 5-HT(1A) receptors or β-adrenoceptors, restrain the citalopram-induced increase in extracellular 5-hydroxytryptamine in vivo

European Journal of Pharmacology

Volumn 316, Issue 1, 1996, Pages 43-47

  Hjorth, Stephan ^a   Bengtsson, H Jörgen ^a   Milano, Stéphane ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Adrenoceptor; 5 HT(1A) autoreceptor; 5 HT(1A) receptor; Antidepressant augmentation; Citalopram; Micradialysis, in vivo; Penbutolol enantiomer; Postsynaptic; Raphe; WAY 100635

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; AUTORECEPTOR; BETAXOLOL; CITALOPRAM; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; PENBUTOLOL; RECEPTOR SUBTYPE; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN ANTAGONIST; SEROTONIN UPTAKE INHIBITOR; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; PIPERAZINE DERIVATIVE; PROPANOLAMINE DERIVATIVE; PYRIDINE DERIVATIVE; SEROTONIN 1 RECEPTOR; SEROTONIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DRUG CEREBROSPINAL FLUID LEVEL; ELECTROCHEMICAL DETECTION; ENANTIOMER; FOREBRAIN; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOCAMPUS; INTRACEREBRAL DRUG ADMINISTRATION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; MESENCEPHALON; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAPHE NUCLEUS; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; ANIMAL; DRUG EFFECT; EXTRACELLULAR SPACE; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT; ULTRASTRUCTURE;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; BETAXOLOL; CITALOPRAM; EXTRACELLULAR SPACE; HIPPOCAMPUS; MALE; MICRODIALYSIS; PENBUTOLOL; PIPERAZINES; PROPANOLAMINES; PYRIDINES; RAPHE NUCLEI; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN; SEROTONIN ANTAGONISTS; SEROTONIN UPTAKE INHIBITORS;

EID: 0030605187     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(96)00779-0     Document Type: Article

References (17)

1. Adell, A., A. Carceller and F. Artigas, 1991, Regional distribution of extracellular 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in the brain of freely moving rats, J. Neurochem. 56, 709.
2. Artigas, F., V. Perez and E. Alvarez, 1994, Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors, Arch. Gen. Psychiatry 51, 248.
3. Bel, N. and F. Artigas, 1992, Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei - an in vivo microdialysis study, Eur. J. Pharmacol. 229, 101.
4. Blier, P. and R. Bergeron, 1995, Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression, J. Clin. Psychopharmacol. 15, 217.
5. Blier, P., C. De Montigny and Y. Chaput, 1987, Modifications of the serotonin system by antidepressant treatments: implications for the therapeutic response in major depression, J. Clin. Psychopharmacol. 7, 24S.
6. Chaput, Y., C. De Montigny and P. Blier, 1991, Presynaptic and postsynaptic modifications of the serotonin system by long-term administration of antidepressant treatments - an in vivo electrophysiologic study in the rat, Neuropsychopharmacology 5, 219.
7. 1A receptors, Neurochem. Res. 21, 557.
8. 1A receptor antagonist, WAY-100635, Eur. J. Pharmacol. 281, 81.
9. 1A receptor antagonist and an SSRI in vivo: effects on 5-HT cell firing and extracellular 5-HT, Br. J. Pharmacol. 115, 1064.
10. 1A autoreceptor blockade potentiates the ability of the 5-HT reuptake inhibitor citalopram to increase nerve terminal output of 5-HT in vivo - a microdialysis study, J. Neurochem. 60, 776.
11. 1A autoreceptors in the effect of 5-HT reuptake blockade on extracellular 5-HT levels in the rat brain, Soc. Neurosci. Abstr. 21, 1368.
12. 1B autoreceptor blocking properties of the beta-adrenoceptor antagonist (-)penbutolol, J. Pharmacol. Exp. Ther. 265, 707.
13. 1A antagonists, WAY100635 and (-)pindolol, augment the 5-HT-elevating effect of the SSRI citalopram in vivo, whereas buspirone does not; systemic and intra-raphe drug injection studies, Nordic J. Psychiat. 50, 96.
14. Invernizzi, R., S. Belli and R. Samanin, 1992, Citalopram's ability to increase the extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortex, Brain Res. 584, 322.
15. Middlemiss, D.N., J. Neill and M.D. Tricklebank, 1985, Subtypes of the 5-HT receptor involved in hypothermia and forepaw treading induced by 8-OH-DPAT, Br. J. Pharmacol. 85, 251P.
16. Paxinos, G. and C. Watson, 1986, The Rat Brain in Stereotaxic Coordinates, 2nd edn. (Academic Press, San Diego).
17. Sharp, T., S.R. Bramwell, D. Clark and D.G. Grahame-Smith, 1989, In vivo measurements of brain extracellular 5-hydroxytryptamine using microdialysis: changes in relation to 5-hydroxytryptaminergic neuronal activity, J. Neurochem. 53, 234.